Our previous study found that the LPTS/PinX1133–328 could inhibit the growth of 7 hepatocellular carcinoma cell lines and 1 hepatic adenocarcinoma cell line (22), emphasizing its potential as a broad-spectrum drug candidate for liver cancer treatment. Here, PINX1 is linked to liver cancer.